Prospective study of scheduled withdrawal from nortriptyline in children and adolescents

Area of Science:

• Pharmacology
• Pediatric Medicine
• Clinical Psychology

Background:

• Nortriptyline is a tricyclic antidepressant used in pediatric populations.
• Abrupt cessation of nortriptyline can lead to withdrawal symptoms.
• Understanding safe discontinuation protocols is crucial for pediatric patients.

Purpose of the Study:

• To evaluate the efficacy of a scheduled tapering protocol for nortriptyline discontinuation in children and adolescents.
• To assess the incidence and severity of withdrawal symptoms during nortriptyline dose reduction.

Main Methods:

• An open-label study involving 30 pediatric subjects aged 6 to 16 years.
• Subjects were gradually tapered from their maintenance dose of nortriptyline.
• Withdrawal effects were systematically monitored throughout the tapering period.

Main Results:

• Five subjects (16.7%) experienced brief gastrointestinal distress.
• No subject required additional doses due to withdrawal symptoms.
• The majority of pediatric patients tolerated scheduled nortriptyline tapering without significant adverse events.

Conclusions:

• Scheduled tapering of nortriptyline appears to be a safe and effective method for discontinuation in pediatric patients.
• This protocol can effectively preclude most withdrawal symptoms.
• Further research may explore long-term outcomes and optimal tapering schedules.